Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Clinical Database of Individuals With Smith-Magenis Syndrome

NCT03154697 is registered in ClinicalTrials.gov with Vanda Pharmaceuticals as lead sponsor.

NCT NCT03154697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Clinical Database of Individuals With Smith-Magenis Syndrome
Lead sponsor
Vanda Pharmaceuticals
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2016
Completion date
December 31, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep disturbances in smith-magenis syndrome